NASDAQ:NVNO

enVVeno Medical Corporation Stock Insider Trading

NASDAQ Stock Exchange > Healthcare > Medical Devices

$5.34

+0.340 (+6.80%)

At Close: Jun 24, 2024

enVVeno Medical Corporation Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 82.17. In total, the insiders bought 6 848 840 and sold 1 971 222 NVNO shares in the last 100 trades.

Insider Power (Last 100 transactions)	82.17
Buy	6 848 840 Shares
Sell	1 971 222 Shares

Historical Insider Trades

Date	Type	Action	Person	Amount
Mar 13, 2024	Stock Options	Sell	Alavi Hamed	8 334
Mar 13, 2024	Common Stock	Buy	Alavi Hamed	8 334
Mar 13, 2024	Common Stock	Sell	Alavi Hamed	8 334
Dec 05, 2023	Stock Options	Buy	Glynn Craig	75 000
Dec 05, 2023	Stock Options	Buy	Jenusaitis Matthew	13 856
Dec 05, 2023	Stock Options	Buy	Alavi Hamed	100 000
Dec 05, 2023	Stock Options	Buy	Glickman Marc H.	100 000
Dec 05, 2023	Stock Options	Buy	Gray Robert	13 856
Dec 05, 2023	Stock Options	Buy	Shrivastava Sanjay	13 856
Dec 05, 2023	Stock Options	Buy	Duhay Francis	13 856
Dec 05, 2023	Stock Options	Buy	Berman Robert Andrew	300 000
Jan 18, 2023	Stock Options	Buy	Alavi Hamed	125 925
Jan 18, 2023	Stock Options	Buy	Alavi Hamed	320 000
Jan 18, 2023	Stock Options	Buy	Alavi Hamed	8 000
Jan 18, 2023	Restricted Stock Unit	Buy	Alavi Hamed	50 000
Nov 30, 2022	Stock Options	Buy	Jenusaitis Matthew	8 403
Nov 30, 2022	Stock Options	Buy	Shrivastava Sanjay	8 403
Nov 30, 2022	Stock Options	Buy	Gray Robert	8 403
Nov 30, 2022	Stock Options	Buy	Duhay Francis	8 403
Sep 13, 2022	Common Stock	Buy	Gray Robert	1 041
Sep 13, 2022	Restricted Stock Units	Sell	Gray Robert	1 041
Sep 13, 2022	Common Stock	Buy	Jenusaitis Matthew	1 041
Sep 13, 2022	Restricted Stock Units	Sell	Jenusaitis Matthew	1 041
Aug 16, 2022	Common Stock	Buy	Duhay Francis	7 751
Jun 30, 2022	Common Stock	Buy	Shrivastava Sanjay	1 000

About enVVeno Medical Corporation

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blo... NVNO Profile

Golden Star

Ticker	Date	Change	Price
SRE	Jun 20	1.29%	$75.48
PEG	Jun 20	1.59%	$73.58
DOC	Jun 20	1.39%	$19.38
FRT	Jun 20	0.0792%	$101.00
BRK-A	Jun 20	1.11%	$617,249.90
ANGL	Jun 20	0.0350%	$28.57
V	Jun 18	0.98%	$273.62
EPD	Jun 18	2.40%	$28.30
USFD	Jun 18	2.30%	$53.14
UFPT	Jun 18	2.69%	$253.79

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In